WPP
NWBO

Whalerock Point Partners’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Whalerock Point Partners’s Portfolio NWBO Stock Details NWBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-60,000
Closed -$16K – 149
2019
Q2 		$16K Buy
60,000
+9,000
+18% +$2.4K 0.01% 145
2019
Q1 		$14K Buy
51,000
+11,000
+28% +$3.02K 0.01% 128
2018
Q4 		$8K Hold
40,000
– – 0.01% 94
2018
Q3 		$8K Buy
40,000
+10,000
+33% +$2K 0.01% 116
2018
Q2 		$8K Hold
30,000
– – 0.01% 118
2018
Q1 		$8K Buy
30,000
+10,000
+50% +$2.67K ﹤0.01% 196
2017
Q4 		$5K Hold
20,000
– – ﹤0.01% 191
2017
Q3 		$4K Buy
+20,000
New +$4K ﹤0.01% 166
2017
Q2 		– Sell
-20,000
Closed -$5K – 174
2017
Q1 		$5K Buy
+20,000
New +$5K ﹤0.01% 151
2016
Q4 		– Sell
-15,000
Closed -$8K – 159
2016
Q3 		$8K Buy
+15,000
New +$6.86K ﹤0.01% 142

Other funds holding NWBO

WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
LDB
Lee, Danner & Bass Nashville, Tennessee $1.59B AUM 23.47% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.2B AUM 18.32% 1-Year Est. Return